First Eagle Investment Management LLC lowered its stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU – Free Report) by 49.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 628,000 shares of the company’s stock after selling 612,000 shares during the quarter. First Eagle Investment Management LLC’s holdings in InfuSystem were worth $8,095,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of INFU. White Pine Capital LLC acquired a new position in shares of InfuSystem in the 3rd quarter valued at about $2,925,000. Ritholtz Wealth Management raised its position in shares of InfuSystem by 31.3% in the third quarter. Ritholtz Wealth Management now owns 84,295 shares of the company’s stock valued at $1,087,000 after purchasing an additional 20,108 shares during the period. North Star Investment Management Corp. grew its position in shares of InfuSystem by 2.3% during the 3rd quarter. North Star Investment Management Corp. now owns 186,150 shares of the company’s stock valued at $2,399,000 after purchasing an additional 4,150 shares in the last quarter. WINTON GROUP Ltd bought a new position in InfuSystem during the second quarter valued at approximately $300,000. Finally, AXQ Capital LP bought a new stake in InfuSystem during the 2nd quarter valued at approximately $98,000. Institutional investors and hedge funds own 71.13% of the company’s stock.
InfuSystem Stock Down 4.2%
INFU stock opened at $14.06 on Friday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $13.58 and its 200 day moving average price is $10.72. InfuSystem Holdings, Inc. has a 52 week low of $7.29 and a 52 week high of $15.47. The company has a market cap of $281.66 million, a P/E ratio of 234.37 and a beta of 1.38.
Analyst Ratings Changes
Separately, B. Riley Financial reiterated a “buy” rating and issued a $20.00 target price (up from $12.00) on shares of InfuSystem in a research report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $17.50.
Read Our Latest Stock Report on InfuSystem
InfuSystem Profile
InfuSystem Holdings, Inc. provides infusion pumps, related medical equipment and support services to healthcare providers and patients. Its products are used in settings such as hospitals, clinics and patients’ homes, including for oncology and pain-management therapies. The company operates through its Integrated Therapy Services and Durable Medical Equipment Services businesses. Its offerings include infusion pump rentals and sales, equipment management, biomedical services, clinical support and related supplies.
Featured Stories
- Five stocks we like better than InfuSystem
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFU – Free Report).
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
